{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:02Z","timestamp":1792598402737,"version":"4.5.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Colorectal cancer liver metastasis is the most frequent and clinically important pattern of distant spread in colorectal cancer and remains a major determinant of poor prognosis and treatment failure. In the era of immunotherapy, liver metastasis has emerged as an organ-specific barrier to effective antitumor immune responses. Clinical and translational evidence suggests that this pattern of resistance is observed across both MSI-H\/dMMR and MSS\/pMMR disease contexts, highlighting the liver metastatic microenvironment as a consistent modifier of immunotherapy response. However, the biological mechanisms by which the liver metastatic environment shapes immunotherapy resistance have not been fully integrated, and the extent to which local hepatic immune suppression influences systemic antitumor immunity remains incompletely defined. This review summarizes the liver-specific biological basis of immunotherapy resistance in colorectal cancer liver metastasis, focusing on three interconnected mechanistic layers, including the pre-existing tolerogenic immune niche of the liver, the local immunosuppressive microenvironment established within liver metastases, and the systemic immune suppression associated with the hepatic sink effect. We further discuss therapeutic strategies aimed at enhancing tumor immunogenicity, reprogramming suppressive myeloid and dendritic cells, restoring the function of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells and innate-like effector lymphocytes, remodeling stromal and vascular barriers, and counteracting liver metastasis-driven systemic immune dysfunction. Future clinical and translational studies should prioritize liver-lesion-specific efficacy, paired primary and metastatic tissue analyses, assessment of liver metastatic burden and activity, and integrated immune biomarkers. A shift from a primary-tumor-centered view toward a liver-microenvironment-oriented framework may provide new opportunities to improve immunotherapy outcomes in patients with colorectal cancer liver metastasis.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1906870","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:24:46Z","timestamp":1787059486000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling"],"prefix":"10.3389","volume":"17","author":[{"given":"Zijing","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Landscape Architecture & Arts, Northwest A&F University","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengshan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Jiangmen Central Hospital","place":["Jiangmen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Zhong","sequence":"additional","affiliation":[{"name":"China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Jie","family":"He","sequence":"additional","affiliation":[{"name":"The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital","place":["Quzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuming","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Jiangmen Central Hospital","place":["Jiangmen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiology, Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University","place":["Jiangmen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Rhinology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: A review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: Esmo clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70097","article-title":"Liver-directed therapies for colorectal liver metastases","volume":"131","author":"Folkerts","year":"2025","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/jco.22.01690","article-title":"Treatment of metastatic colorectal cancer: Asco guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: Mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S500281","article-title":"Progress of immune checkpoint inhibitors therapy for pmmr\/mss metastatic colorectal cancer","volume":"17","author":"Qu","year":"2024","journal-title":"Onco Targets Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00369","article-title":"Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer","volume":"11","author":"Picard","year":"2020","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17243984","article-title":"Can tp53, tmb and tme expand the immunotherapy benefit in metastatic colorectal cancer","volume":"17","author":"Specchia","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108017","article-title":"Strategic enhancement of immune checkpoint inhibition in refractory colorectal cancer: Trends and future prospective","volume":"99","author":"Liu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-26-0542","article-title":"Mismatch repair-proficient colorectal cancer can evade immune surveillance through an intrinsic suppressive program","author":"Cattaneo","year":"2026","journal-title":"Cancer Discov"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated t cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0400","article-title":"Association between survival and metastatic site in mismatch repair-deficient metastatic colorectal cancer treated with first-line pembrolizumab","volume":"6","author":"Saberzadeh-Ardestani","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03083-7","article-title":"Botensilimab plus balstilimab in relapsed\/refractory microsatellite stable metastatic colorectal cancer: A phase 1 trial","volume":"30","author":"Bullock","year":"2024","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba0759","article-title":"Regulatory t cell control of systemic immunity and immunotherapy response in liver metastasis","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000491","article-title":"Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context","volume":"8","author":"Guillot","year":"2024","journal-title":"Hepatol Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121657","article-title":"Molecular mechanisms of colorectal liver metastases","volume":"12","author":"Tsilimigras","year":"2023","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: A comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J Autoimmun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1503063","article-title":"The liver's dilemma: Sensing real danger in a sea of pamps: The (arterial) sinusoidal segment theory","volume":"15","author":"Henriques-Pons","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1783588","article-title":"Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver disease","volume":"17","author":"\u00c1ngel-Gomis","year":"2026","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-026-01288-0","article-title":"Kupffer cells in liver homeostasis and disease: From immune sentinels to metabolic gatekeepers","volume":"26","author":"Araujo David","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26093988","article-title":"Liver sinusoidal endothelial cells in the regulation of immune responses and fibrosis in metabolic dysfunction-associated fatty liver disease","volume":"26","author":"Puri","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes b7-homolog 1-dependent cd8+ t cell tolerance","volume":"47","author":"Diehl","year":"2008","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197378","article-title":"Dendritic cell and t cell crosstalk in liver fibrogenesis and hepatocarcinogenesis: Implications for prevention and therapy of liver cancer","volume":"21","author":"Lurje","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201937","article-title":"Hepatic stellate cells preferentially induce foxp3+ regulatory t cells by production of retinoic acid","volume":"190","author":"Dunham","year":"2013","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01203","article-title":"The role of diverse liver cells in liver transplantation tolerance","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients","volume":"250","author":"de Jong","year":"2009","journal-title":"Ann Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10191","article-title":"Factors influencing recurrence following initial hepatectomy for colorectal liver metastases","volume":"103","author":"Hallet","year":"2016","journal-title":"Br J Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/xcs.0000000000000223","article-title":"Colorectal liver micrometastases: Association with ras\/tp53 co-mutation and prognosis after surgery","volume":"235","author":"Chun","year":"2022","journal-title":"J Am Coll Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.06.009","article-title":"Spatial multi-omics landscape of colorectal cancer macro- and micrometastases","author":"Liu","year":"2026","journal-title":"Cancer Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of wnt","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03614-z","article-title":"Hepatic stellate cells suppress nk cell-sustained breast cancer dormancy","volume":"594","author":"Correia","year":"2021","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-15-1591","article-title":"Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress","volume":"76","author":"Tohme","year":"2016","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70000","article-title":"The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells","volume":"5","author":"Garcia-Vici\u00e9n","year":"2024","journal-title":"MedComm (2020)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01713-1","article-title":"Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution","volume":"22","author":"Fleischer","year":"2023","journal-title":"Mol Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/path.5449","article-title":"Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy","volume":"251","author":"Palmieri","year":"2020","journal-title":"J Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030689","article-title":"Spatial immunology in liver metastases from colorectal carcinoma according to the histologic growth pattern","volume":"14","author":"Garcia-Vici\u00e9n","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2020.1721252","article-title":"Neoadjuvant chemotherapy is associated with a transient increase of intratumoral t-cell density in microsatellite stable colorectal liver metastases","volume":"21","author":"Dagenborg","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2020.04.045","article-title":"Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials","volume":"135","author":"Moretto","year":"2020","journal-title":"Eur J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02526","article-title":"A non-interventional clinical trial assessing immune responses after radiofrequency ablation of liver metastases from colorectal cancer","volume":"10","author":"L\u00f6ffler","year":"2019","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35252","article-title":"Prognostic assessment of t-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis","volume":"156","author":"Trailin","year":"2025","journal-title":"Int J Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3446-6","article-title":"Increased infiltration of natural killer and t cells in colorectal liver metastases improves patient overall survival","volume":"21","author":"Donadon","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105323118","article-title":"Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy","volume":"118","author":"Ho","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1199","article-title":"Mature dendritic cells enriched in immunoregulatory molecules (mregdcs): A novel population in the tumour microenvironment and immunotherapy target","volume":"13","author":"Li","year":"2023","journal-title":"Clin Transl Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41467-024-44787-1","article-title":"Tumour-retained activated ccr7(+) dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity","volume":"15","author":"Lee","year":"2024","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-021-00312-y","article-title":"A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy","volume":"7","author":"Che","year":"2021","journal-title":"Cell Discov"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06203-8","article-title":"Comparison of immune microenvironment between colon and liver metastatic tissue in colon cancer patients with liver metastasis","volume":"66","author":"Zhou","year":"2021","journal-title":"Dig Dis Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-020-02636-x","article-title":"Pd-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer","volume":"18","author":"Wei","year":"2020","journal-title":"J Transl Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70137","article-title":"Mgp promotes Cd8(+) T cell exhaustion by activating the Nf-Kappab pathway leading to liver metastasis of colorectal cancer","volume":"18","author":"Rong","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13046-023-02803-0","article-title":"Chsy1 promotes Cd8(+) T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on Crispr\/Cas9 screening","volume":"42","author":"Sun","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-3296","article-title":"Tissue-resident T cells in clinical response and immune-related adverse events of immune checkpoint blockade","volume":"30","author":"Zhao","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104876","article-title":"Tissue-resident memory Cd8(+) T cells in cancer immunology and immunotherapy","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2025.2455176","article-title":"Liver metastases of colorectal cancer contain different subsets of tissue-resident memory Cd8 T cells correlated with a distinct risk of relapse following surgery","volume":"14","author":"Abdeljaoued","year":"2025","journal-title":"Oncoimmunology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17977-4","article-title":"Cd103-positive tumor-infiltrating lymphocytes predict a favorable prognosis in colorectal cancer with liver metastasis","volume":"33","author":"Wu","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-180","article-title":"T cells but not Nk cells are associated with a favourable outcome for resected colorectal liver metastases","volume":"14","author":"Pugh","year":"2014","journal-title":"BMC Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","article-title":"Immune phenotypic linkage between colorectal cancer and liver metastasis","volume":"40","author":"Liu","year":"2022","journal-title":"Cancer Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e184036","DOI":"10.1172\/jci184036","article-title":"Cxcr3 promotes protection from colorectal cancer liver metastasis by driving Nk cell infiltration and plasticity","volume":"135","author":"Russo","year":"2025","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/jci190778","article-title":"Tissue-specific antitumor Nk cell subsets identified in colorectal cancer liver metastases express candidate therapeutic targets","volume":"135","author":"Mikulak","year":"2025","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf5464","article-title":"Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer","volume":"9","author":"Wang","year":"2023","journal-title":"Sci Adv"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nature24293","article-title":"Il-1r8 is a checkpoint in Nk cells regulating anti-tumour and anti-viral activity","volume":"551","author":"Molgora","year":"2017","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004579","article-title":"Intrahepatic Cd69(+)Vdelta1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression","volume":"10","author":"Bruni","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102579","article-title":"Liver metastases dampen Il18-driven Gammadelta T cell activity and immunotherapy responsiveness in colorectal cancer","volume":"7","author":"van Renterghem","year":"2026","journal-title":"Cell Rep Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2026.157820","article-title":"Xiao-Yao-San suppresses psychological distress-related colorectal cancer metastasis and enhances antitumor immune responses through regulating gut microbiota-bile acid axis","volume":"152","author":"Hou","year":"2026","journal-title":"Phytomedicine"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191847","article-title":"Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis","volume":"217","author":"Donadon","year":"2020","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201259","article-title":"Cancer metastasis linked to macrophage size, shape, and metabolism","volume":"217","author":"Murray","year":"2020","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-22-0462","article-title":"High-resolution analysis of mononuclear phagocytes reveals Gpnmb as a prognostic marker in human colorectal liver metastasis","volume":"11","author":"Cortese","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-25-0031","article-title":"Tissue-specific immunosuppressive and proliferating macrophages fuel early metastatic progression of human colorectal cancer to the liver","volume":"13","author":"Marzano","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002841","article-title":"Cd11b(+)Ctla4(+) myeloid cells are a key driver of tumor evasion in colorectal cancer","volume":"9","author":"Imazeki","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm8660","article-title":"Targeting conserved Tim3(+)Vista(+) tumor-associated macrophages overcomes resistance to cancer immunotherapy","volume":"10","author":"Vanmeerbeek","year":"2024","journal-title":"Sci Adv"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.Crc-22-0295","article-title":"A Prrx1 signature identifies Tim-3 and Vista as potential immune checkpoint targets in a subgroup of microsatellite stable colorectal cancer liver metastases","volume":"3","author":"Nygaard","year":"2023","journal-title":"Cancer Res Commun"},{"key":"B75","article-title":"Cd11b(+)Dip2a(+)Lag3(+) cells facilitate immune dysfunction in colorectal cancer","volume":"11","author":"Kudo-Saito","year":"2021","journal-title":"Am J Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-026-02510-w","article-title":"Kupffer cell calibration of T cell responses via Vsig4-Cd5 interaction promotes tumor evasion","volume":"27","author":"Zhou","year":"2026","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030496","article-title":"Ido1\/Cox2 expression is associated with poor prognosis in colorectal cancer liver oligometastases","volume":"13","author":"Wu","year":"2023","journal-title":"J Pers Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259940","article-title":"The role of the immunoescape in colorectal cancer liver metastasis","volume":"16","author":"Takasu","year":"2021","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02380-2","article-title":"Tgf-beta builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive Spp1(+) macrophages","volume":"57","author":"Henriques","year":"2025","journal-title":"Nat Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100383","article-title":"Regorafenib plus Toripalimab in patients with metastatic colorectal cancer: a phase Ib\/Ii clinical trial and gut microbiome analysis","volume":"2","author":"Wang","year":"2021","journal-title":"Cell Rep Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2019.10.016","article-title":"Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases","volume":"470","author":"Zhang","year":"2020","journal-title":"Cancer Lett"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c01676","article-title":"Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis","volume":"14","author":"Guo","year":"2020","journal-title":"ACS Nano"},{"key":"B83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-023-02804-z","article-title":"Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape","volume":"42","author":"Ma","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0347625","article-title":"Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver","volume":"21","author":"Yang","year":"2026","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1038\/s41598-025-97667-z","article-title":"Pdt-regulated immune gene prognostic model reveals tumor microenvironment in colorectal cancer liver metastases","volume":"15","author":"Xu","year":"2025","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01226-y","article-title":"Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis","volume":"14","author":"Kuang","year":"2022","journal-title":"Clin Epigenet"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2024.03.002","article-title":"Pembrolizumab plus binimetinib with or without chemotherapy for Mss\/Pmmr metastatic colorectal cancer: outcomes from Keynote-651 cohorts a, C, and E","volume":"23","author":"Chen","year":"2024","journal-title":"Clin Colorectal Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005640","article-title":"Phase I\/Ii study of Pexavec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer","volume":"11","author":"Monge","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.1038\/s41467-024-51536-x","article-title":"Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and Ras wild-type metastatic colorectal cancer: a single-arm phase 2 study","volume":"15","author":"Xu","year":"2024","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167035","article-title":"Nlrp6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-Mdsc-induced immunosuppressive microenvironment","volume":"1870","author":"Chang","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-2123","article-title":"Th17 cells secrete Tweak to trigger epithelial-mesenchymal transition and promote colorectal cancer liver metastasis","volume":"84","author":"Liu","year":"2024","journal-title":"Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ccell.2023.09.014","article-title":"In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases","volume":"41","author":"Kerzel","year":"2023","journal-title":"Cancer Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1514158","article-title":"Stachydrine targeting tumor-associated macrophages inhibit colorectal cancer liver metastasis by regulating the Jak2\/Stat3 pathway","volume":"16","author":"Gui","year":"2025","journal-title":"Front Pharmacol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-024-02086-9","article-title":"Targeting Circ-0034880-enriched tumor extracellular vesicles to impede Spp1(high)Cd206(+) pro-tumor macrophages mediated pre-metastatic niche formation in colorectal cancer liver metastasis","volume":"23","author":"Zhou","year":"2024","journal-title":"Mol Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006481","article-title":"Macrophage Sting signaling promotes Nk cell to suppress colorectal cancer liver metastasis via 4-1bbl\/4-1bb co-stimulation","volume":"11","author":"Sun","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-026-02732-2","article-title":"Eno2 drives tumor cell-induced M2 macrophage polarization to promote colorectal cancer liver metastasis","volume":"11","author":"Tang","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1105244","article-title":"Dendritic cell phenotype and function in a 3d co-culture model of patient-derived metastatic colorectal cancer organoids","volume":"14","author":"Subtil","year":"2023","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of liver metastasis stiffness improves response to Bevacizumab in metastatic colorectal cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.04.001","article-title":"Multifunctional nanodrug performs sonodynamic therapy and inhibits Tgf-\u03b2 to boost immune response against colorectal cancer and liver metastasis","volume":"164","author":"Huang","year":"2023","journal-title":"Acta Biomater"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.12.015","article-title":"Il-10 dampens antitumor immunity and promotes liver metastasis via Pd-L1 induction","volume":"80","author":"Shiri","year":"2024","journal-title":"J Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70047","article-title":"Targeting Sphk1 in macrophages remodels the tumor microenvironment and enhances anti-Pd-1 immunotherapy efficacy in colorectal cancer liver metastasis","volume":"45","author":"Zhan","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-20-2474","article-title":"Phase ii single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair-proficient metastatic colorectal cancer","volume":"27","author":"Segal","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-21-2269","article-title":"Nanoparticle delivery of Mir-122 inhibits colorectal cancer liver metastasis","volume":"82","author":"Sendi","year":"2022","journal-title":"Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008689","article-title":"Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: The phase ii Checkmate 142 study","volume":"12","author":"Overman","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.49040","article-title":"Assessment of capecitabine and bevacizumab with or without atezolizumab for the treatment of refractory metastatic colorectal cancer: A randomized clinical trial","volume":"5","author":"Mettu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02497-z","article-title":"First-line durvalumab and tremelimumab with chemotherapy in Ras-mutated metastatic colorectal cancer: A phase 1b\/2 trial","volume":"29","author":"Thibaudin","year":"2023","journal-title":"Nat Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00274-1","article-title":"Upfront Folfoxiri plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (Atezotribe): A multicentre, open-label, randomised, controlled, phase 2 trial","volume":"23","author":"Antoniotti","year":"2022","journal-title":"Lancet Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-20-1803","article-title":"Multicenter phase i\/ii trial of napabucasin and pembrolizumab in patients with metastatic colorectal cancer (Epoc1503\/Scoop trial)","volume":"26","author":"Kawazoe","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.03.017","article-title":"Pembrolizumab and maraviroc in refractory mismatch repair proficient\/microsatellite-stable metastatic colorectal cancer - the Piccasso phase i trial","volume":"167","author":"Haag","year":"2022","journal-title":"Eur J Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102315","article-title":"Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: An open-label, single-arm, phase ii trial (Renmin-215)","volume":"66","author":"Zhao","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.12.014","article-title":"Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: The randomized Cave-2 Goim trial","volume":"37","author":"Ciardiello","year":"2026","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1906870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:24:47Z","timestamp":1787059487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1906870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":111,"alternative-id":["10.3389\/fimmu.2026.1906870"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1906870","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1906870"}}